Financial performances Comparison is as follows: THB’000 Q2/2017 Q2/2016 YoY Q1/2017 QoQ Revenue from sales and services 704,817 896,447 -21% 870,845 -19% Interest income 485 769 -37% 363 34% Other income
) FY2019 Management Discussion and Analysis Financial Statement Summary in FY2019 Statement of Comprehensive Income Total Revenue Total revenue from the core business in FY2019 was Bt3,147.35mn, decreasing
222 Production 2H17 Annualised (MMT) 9.4 3.8 1.4 4.2 3.6 2.8 3.0 EBITDA ($/t) 117 92 152 128 137 140 73 Net Op CE as on Dec'17 ($B) 5.6 Simple payback of existing businesses 5.1 years Increase in
222 Production 2H17 Annualised (MMT) 9.4 3.8 1.4 4.2 3.6 2.8 3.0 EBITDA ($/t) 117 92 152 128 137 140 73 Net Op CE as on Dec'17 ($B) 5.6 Simple payback of existing businesses 5.1 years Increase in
million in net profit, increasing Baht 151 million or 1.40 percent over-quarter. The increase came from net interest income, which rose Baht 671 million, or 2.83 percent. Net interest margin (NIM) was equal
. Income from medical treatments in the consolidated financial Statement went up 6.81% due to income from Chiang Mai Ram Medical Business Plc.”CMR”, a subsidiary amount Baht 3,747.64 million went up from
ended 31 March 2021 which was reviewed by the auditor. The Company’s overall performance can be summarized as follows: Performance (Statement of comprehensive income) 1Q2021 1Q2020 Increase/ (Decrease
which was audited by the auditor. The Company’s overall performance can be summarized as follows: Performance Unit: THB Million 2022 2023 Inc.(Dec.) % Inc.(Dec.) Services income 331.18 317.89 (13.29
results of WIIK and its subsidiaries for the three-month period ended September 30, 2019 as follows. Summarized of the Statement of income Unit : million Baht Quarter 3/2019 Quarter 3/2018 Changed
Sir, Please find below the additional information in supportive of our financial statements ended June 30, 2018. Performance for the three-month period ended June 30, 2018 - Sales income increased 4.8